XENOBIOTIC LABORATORIES INC

Xenobiotic Laboratories Inc. specializes in scientific research and technical services within the life sciences and biomedical domains, leveraging expertise in analytical chemistry, toxicology, and bioanalytical method development. The company delivers contract research services that support regulatory compliance, environmental health assessments, and pharmaceutical safety evaluations, with a focus on advanced laboratory testing, data interpretation, and method validation under GLP and GMP frameworks. Their technical capabilities include sample preparation, chromatographic analysis, mass spectrometry, and biomarker quantification, serving clients requiring rigorous, reproducible scientific outcomes for federal and public health applications. Differentiators include precision in complex matrix analysis and deep familiarity with EPA, FDA, and NIH testing standards. No award history is available to confirm specific agency engagements, so no definitive patterns of agency relationships can be inferred. Similarly, without contract data, no primary NAICS categories can be identified beyond the primary classification of 541714, which corresponds to research and development in the physical, engineering, and life sciences. In practice, this implies a focus on laboratory-based R&D services rather than product manufacturing or clinical trial management. The company operates as a small business under the 2L entity structure, with its primary presence in Plainsboro, New Jersey. It holds no active government certifications such as 8(a), HUBZone, or WOSB. Its market positioning is defined by niche scientific expertise in analytical services, likely supporting government-funded research initiatives, environmental monitoring programs, or regulatory review pipelines. Without public award records, its scale and reach remain confined to inferred technical capacity rather than documented contract performance.